ibd: switching from a biologic to a biosimilar
Published 3 years ago • 548 plays • Length 5:34Download video MP4
Download video MP3
Similar videos
-
1:30
switching from a biologic to biosimilar drug for ibd in ontario
-
10:00
ibd clinical case: the process of switching from a reference biologic to a biosimilar
-
2:21
switching from a biologic to a biosimilar drug in canada
-
1:21
a guide to transitioning to biologic therapy for ibd
-
1:22:22
making the switch from biologics to biosimilars in ibd: knowledge over skepticism
-
7:22
inflammatory bowel disease
-
3:33
biosimilars: manufacturing and inherent variation
-
7:16
being on inflectra after being on remicade with crohns disease
-
2:23
what to know before switching from biologics to biosimilars?
-
44:11
biosimilars for ibd: making the transition webinar
-
1:08
the impact of switching from a reference biologic to a biosimilar
-
18:23
biosimilars for ibd: to start, switch, or stay away?
-
11:40
debate: biosimilar therapies - caution, more studies are needed
-
21:38
dietary updates and recommendations for the ibd patient on a biosimilar: full version
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
39:51
why ibd patients should know about biosimilars
-
23:19
navigating insurance as a crohn's or colitis patient: what is a biosimilar?
-
4:04
biosimilars and inflammatory bowel disease
-
20:47
biosimilars for ibd: start, switch, or stay away?
-
18:03
understanding the contraindications to the use of immunomodulators and biologics for ibd
-
21:14
when and how to use immunomodulators and biologics in ibd
-
1:33:50
biologic and biosimilar medications for inflammatory bowel disease (ibd)